retatrutide clinical trials netherlands Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced Lilly's 'triple G' agonist triumphs

You can sit down for a break, and your body tries to take a full nap without your permission

In a 49-page decision issued December 31, the Lehigh County Court of Common Pleas concluded that the plaintiff failed to satisfy four of the five requirements for class certification under Pennsylvania law

Keep in mind that the external part of your window may be covered by your COAs insurance policy, while the interior may be covered by your individual condo insurance policy

Large observational studies have suggested lower rates of cognitive decline and dementia among people using GLP-1 medications compared with other diabetes treatments

If you prefer less to remember, injectables might fit better.

Wunsch and Matuschka 2014 in Photomedicine and Laser Surgery (32(2):93-100, PMC3926176) documented statistically significant improvements in skin complexion, fine lines, wrinkles, skin roughness, and intradermal collagen density in subjects treated with red and near-infrared light